The prevalence of airway obstruction among Japanese HIV-positive male patients compared with general population; A case-control study of single center analysis

Journal of Infection and Chemotherapy

Volumn 20, Issue 6, 2014, Pages 361-364

  Nakamura, Hideta ^a   Tateyama, Masao ^a   Tasato, Daisuke ^a   Haranaga, Shusaku ^a   Ishimine, Tomohiko ^b   Higa, Futoshi ^a   Kaneshima, Hiroshi ^c   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Dept of Ophthalmol   (Japan)

^c Omoromachi Medical Center   (Japan)

Author keywords

Airway colonization of Pneumocystis jirovecii; Airway obstruction; HIV; Smoking

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FUNGAL COLONIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL RECORD REVIEW; PNEUMOCYSTIS JIROVECI; POPULATION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SELF REPORT; SMOKING; SPIROMETRY; SPUTUM EXAMINATION; TREATMENT DURATION; VIRUS LOAD; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; JAPAN; MICROBIOLOGY; PATHOPHYSIOLOGY; PNEUMONIA, PNEUMOCYSTIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VIROLOGY;

ADULT; CASE-CONTROL STUDIES; HIV; HIV INFECTIONS; HUMANS; JAPAN; MALE; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SPIROMETRY;

EID: 84903698685     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.02.001     Document Type: Article

References (27)

1. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007;146: 87-95.
2. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008;300: 51-9.
3. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356: 1723-35.
4. Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci 2008;335: 89-94.
5. Poirier CD, Inhaber N, Lalonde RG, Ernst P. Prevalence of bronchial hyperresponsiveness among HIV-infected men. Am J Respir Crit Care Med 2001;164: 542-5.
6. Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, et al. Increased risk of Pneumocystis carinii and communityacquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 2005;4: 208-17.
7. Diaz PT, King MA, Pacht ER, Wewers MD, Gadek JE, Nagaraja HN, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000;132: 369-72.
8. Morris A, Alexander T, Radhi S, Lucht L, Sciurba FC, Kolls JK, et al. Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol 2009;47: 3773-6.
9. Shipley TW, Kiling HM, Morris A, Patil S, Kristoff J, Guyach SE, et al. Persistent pneumocystis colonization leads to development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis 2010;202: 302-12.
10. Kling HM, Shipley TW, Patil SP, Kristoff J, Bryan M, Montelaro RC, et al. Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun 2010;78: 4320-30.
11. van Griensven F, de Lind van Wijngaarden JW. A review of the epidemiology of HIV infection and prevention responses among MSM in Asia. AIDS 2010;(Suppl. 3):S30-40.
12. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 2004;9: 458-65.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:s77-121.
14. Matos O, Costa MC, Lundgen B, Caldeira L, Aguiar P, Antunes F. Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis 2001;20: 573-5.
15. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006;130: 1326-33.
16. Plata F, Autran B, Martins LP, Wain-Hobson S, Raphael M, Mayaud C, et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 1987;328: 348-51.
17. Twigg HL, Soliman DM, Day RB, Know KS, Anderson RJ, Wilkes DS, et al. Lymphocytic aleolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999;59(5 Pt 1): 1439-44.
18. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman Jr HA, et al. Interferon gamma induction of pulmonary emphysema in adult murine lung. J Exp Med 2000;192: 1587-600.
19. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and risk of myocardial infarction. N Engl J Med 2003;349: 1993-2003.
20. Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, et al. Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2007;21: 2445-53.
21. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006;20: 2165-74.
22. Mitchell DM, Fleming J, Pinching AJ, Harris JR, Moss FM, Veale D, et al. Pulmonary function in human immunodeficiency virus infection: a prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis 1992;146: 745-51.
23. Shaw RJ, Roussak C, Forster SM, Harris JR, Pinching AJ, Mitchell DM. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax 1998;43: 436-40.
24. Morris AM, Huang L, Bacchetti P, Tuner J, Hopewell PC, Wallace JM, et al., The Pulmonary Complications of HIV Infection Study Group. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. Am J Respir Crit Care Med 2000;162: 612-6.
25. Morris A, Sciurba FC, Lebedeva IP, Githaiga A, Elliott WM, Hogg JC, et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004;170: 408-13.
26. Morris A, Kingsley LA, Groner G, Lebedeva IP, Beard CB, Norris KA. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004;26: 793-8.
27. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008;197: 10-7.